Dr. Erica Schwartz is the CDC’s 22nd director. | Wikimedia Commons photo
What you probably already know: Dr. Erica Schwartz made history Aug. 5 when she became the first Black woman to lead the Centers for Disease Control and Prevention. She inherits an agency whose credibility has been tested in recent years, beginning with the Covid-19 pandemic to changing vaccine recommendations. Many analysts say restoring public trust among one of the world’s foremost public health institutions could be her greatest challenge amid seemingly never-ending political battles. She becomes the CDC’s 22nd director. Schwartz was nominated by President Donald Trump in April and was confirmed by the U.S. Senate yesterday in a 51-44 vote.
Why it matters: Though Schwartz said during the Senate hearings that she “will never betray the science,” pledging “radical transparency,” several health advocacy groups reacted with both tepid optimism or downright skepticism. When previously asked if she would resist political interference from Health and Human Services Secretary Robert F. Kennedy Jr., for example, she simply said she would base her decisions on science and act with integrity, an answer Reuters reports alarmed some senators. The American Public Health Association released a statement that said it “looks forward to working with her to rebuild trust in public health leaders,” noting that she possesses the medical background and public health knowledge to lead the agency. “With all the turmoil of the past two years, CDC desperately needs stability, experienced leadership and a steadfast commitment to science. We’re rooting for her.”
What it means: Schwartz, 54, is a physician, attorney and retired rear admiral in the U.S. Public Health Service with decades of experience in military medicine. She previously served as chief medical officer for the U.S. Coast Guard and later as deputy surgeon general during the first Trump administration. Supporters cite her management experience and familiarity with federal agencies during a turbulent time for the agency. The Associated Press notes that she is the third Trump nominee for CDC director in the past 18 months. The agency has lost 3,000 employees since Trump’s second term — more than one-quarter of its workforce — due largely to layoffs and resignations.
What happens next: During her confirmation hearing, Schwartz sought to reassure lawmakers that scientific evidence rather than politics would guide her decisions, adding that maintaining the integrity of the CDC’s scientific work would be her top priority. “I have been in situations where I have had to go to my superiors in the military to have conversations, very difficult conversations, about things that may have been concerning to the troops or to the military personnel,” she told senators during a hearing last month, according to ABC News. “I will do the same with (Secretary Robert F. Kennedy Jr.”)
